Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Reply to Correspondence

Reply to correspondence on “Aberrant fragmentomic features of circulating cell-free mitochondrial DNA enable early detection and prognosis prediction of hepatocellular carcinoma”

Hyuk Soo Eun

Clin Mol Hepatol. 2025;31(2):e215-e217. Published online January 16, 2025

DOI: https://doi.org/10.3350/cmh.2025.0035

View: 662 Download: 19

Correspondence

Correspondence to editorial on “Prediction of primary biliary cholangitis among health check-up population with anti-mitochondrial M2 antibody positive”

Haolong Li, Song Liu, Xu Wang, Li Wang, Tengda Xu, Yongzhe Li

Clin Mol Hepatol. 2025;31(2):e194-e196. Published online February 24, 2025

DOI: https://doi.org/10.3350/cmh.2025.0181

View: 591 Download: 28

Editorial

Circulating cell-free mitochondrial DNA for diagnosing hepatocellular carcinoma and assessing prognosis: Editorial on “Aberrant fragmentomic features of circulating cell-free mitochondrial DNA enable early detection and prognosis prediction of hepatocellular carcinoma”

Hyuk soo Eun

Clin Mol Hepatol. 2025;31(2):599-602. Published online December 26, 2024

DOI: https://doi.org/10.3350/cmh.2024.1133

View: 757 Download: 41 Crossref: 2

Correspondence

Correspondence to editorial on: “Gut microbiome and metabolome signatures in liver cirrhosis-related complications”

Satya Priya Sharma, Ki Tae Suk

Clin Mol Hepatol. 2025;31(1):e74-e77. Published online October 15, 2024

DOI: https://doi.org/10.3350/cmh.2024.0872

View: 1226 Download: 48

Original Article

Aberrant fragmentomic features of circulating cell-free mitochondrial DNA enable early detection and prognosis prediction of hepatocellular carcinoma

Yang Liu, Fan Peng, Siyuan Wang, Huanmin Jiao, Kaixiang Zhou, Wenjie Guo, Shanshan Guo, Miao Dang, Huanqin Zhang, Weizheng Zhou, Xu Guo, Jinliang Xing

Clin Mol Hepatol. 2025;31(1):196-212. Published online October 15, 2024

DOI: https://doi.org/10.3350/cmh.2024.0527

View: 1688 Download: 178 Web of Science: 2 Crossref: 2

Reply to Correspondence

Reply to correspondence on “Comparison of four histological scoring systems for autoimmune hepatitis to improve diagnostic sensitivity”

Atsumasa Komori

Clin Mol Hepatol. 2024;30(4):1035-1036. Published online April 11, 2024

DOI: https://doi.org/10.3350/cmh.2024.0242

View: 1680 Download: 40

Correspondence

Reply to: “Evaluation of the histological scoring systems of autoimmune hepatitis: A significant step towards the optimization of clinical diagnosis”

Haeryoung Kim, Sook-Hyang Jeong

Clin Mol Hepatol. 2024;30(2):291-292. Published online March 19, 2024

DOI: https://doi.org/10.3350/cmh.2024.0180

View: 2589 Download: 47 Web of Science: 1 Crossref: 1

Original Article

Comparison of four histological scoring systems for autoimmune hepatitis to improve diagnostic sensitivity

Soomin Ahn, Sook-Hyang Jeong, Eun Ju Cho, Kyoungbun Lee, Gilhyang Kim, Haeryoung Kim

Clin Mol Hepatol. 2024;30(1):37-48. Published online November 13, 2023

DOI: https://doi.org/10.3350/cmh.2023.0325

View: 3788 Download: 227 Web of Science: 4 Crossref: 7

Review

Non-alcoholic fatty liver disease: the pathologist’s perspective

Wei-Qiang Leow, Anthony Wing-Hung Chan, Paulo Giovanni L. Mendoza, Regina Lo, Kihan Yap, Haeryoung Kim

Clin Mol Hepatol. 2023;29(Suppl):S302-S318. Published online November 15, 2022

DOI: https://doi.org/10.3350/cmh.2022.0329

View: 7359 Download: 318 Web of Science: 23 Crossref: 24

Surveillance of the progression and assessment of treatment endpoints for nonalcoholic steatohepatitis

Yi-wen Shi, Jian-Gao Fan

Clin Mol Hepatol. 2023;29(Suppl):S228-S243. Published online December 14, 2022

DOI: https://doi.org/10.3350/cmh.2022.0401

View: 5096 Download: 125 Web of Science: 4 Crossref: 4

Guideline

KASL clinical practice guidelines for management of autoimmune hepatitis 2022

The Korean Association for the Study of the Liver (KASL)

Clin Mol Hepatol. 2023;29(3):542-592. Published online May 3, 2023

DOI: https://doi.org/10.3350/cmh.2023.0087

View: 6809 Download: 383 Web of Science: 7 Crossref: 10

Editorial

What should be done to reduce the discrepancy between guidelines and real-life practice for hepatocellular carcinoma in Korea?

Min Kyung Park, Yoon Jun Kim

Clin Mol Hepatol. 2023;29(2):332-334. Published online March 16, 2023

DOI: https://doi.org/10.3350/cmh.2023.0080

View: 3631 Download: 63 Web of Science: 1 Crossref: 1

Review

Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Chinese perspective

Diyang Xie, Jieyi Shi, Jian Zhou, Jia Fan, Qiang Gao

Clin Mol Hepatol. 2023;29(2):206-216. Published online December 22, 2022

DOI: https://doi.org/10.3350/cmh.2022.0402

View: 10496 Download: 532 Web of Science: 75 Crossref: 72

Clinical practice guideline and real-life practice in hepatocellular carcinoma: A Korean perspective

Myung Ji Goh, Dong Hyun Sinn, Jong Man Kim, Min Woo Lee, Dong Ho Hyun, Jeong Il Yu, Jung Yong Hong, Moon Seok Choi

Clin Mol Hepatol. 2023;29(2):197-205. Published online January 5, 2023

DOI: https://doi.org/10.3350/cmh.2022.0404

View: 6112 Download: 260 Web of Science: 19 Crossref: 21

Guideline

2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma

Korean Liver Cancer Association (KLCA) and National Cancer Center (NCC) Korea

Clin Mol Hepatol. 2022;28(4):583-705. Published online October 1, 2022

DOI: https://doi.org/10.3350/cmh.2022.0294

View: 18658 Download: 840 Web of Science: 173 Crossref: 192

Review

Imaging diagnosis of hepatocellular carcinoma: Future directions with special emphasis on hepatobiliary magnetic resonance imaging and contrast-enhanced ultrasound

Junghoan Park, Jeong Min Lee, Tae-Hyung Kim, Jeong Hee Yoon

Clin Mol Hepatol. 2022;28(3):362-379. Published online December 27, 2021

DOI: https://doi.org/10.3350/cmh.2021.0361

View: 7741 Download: 253 Web of Science: 21 Crossref: 23

Original Article

Serum milk fat globule-EGF factor 8 protein as a potential biomarker for metabolic syndrome

Han Ah Lee, Jihwan Lim, Hyung Joon Joo, Young-Sun Lee, Young Kul Jung, Ji Hoon Kim, Hyunggin An, Hyung Joon Yim, Yoon Tae Jeen, Jong Eun Yeon, Do-Sun Lim, Kwan Soo Byun, Yeon Seok Seo

Clin Mol Hepatol. 2021;27(3):463-473. Published online February 15, 2021

DOI: https://doi.org/10.3350/cmh.2020.0351

View: 6794 Download: 180 Web of Science: 4 Crossref: 4

Guideline

KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease

Seong Hee Kang, Hye Won Lee, Jeong-Ju Yoo, Yuri Cho, Seung Up Kim, Tae Hee Lee, Byoung Kuk Jang, Sang Gyune Kim, Sang Bong Ahn, Haeryoung Kim, Dae Won Jun, Joon-Il Choi, Do Seon Song, Won Kim, Soung Won Jeong, Moon Young Kim, Hong Koh, Sujin Jeong, Jin-Woo Lee, Yong Kyun Cho, on behalf of The Korean Association for the Study of the Liver (KASL)

Clin Mol Hepatol. 2021;27(3):363-401. Published online June 22, 2021

DOI: https://doi.org/10.3350/cmh.2021.0178

View: 23813 Download: 1,273 Web of Science: 178 Crossref: 190

Review

Recent updates on the management of autoimmune hepatitis

Atsumasa Komori

Clin Mol Hepatol. 2021;27(1):58-69. Published online December 10, 2020

DOI: https://doi.org/10.3350/cmh.2020.0189

View: 18906 Download: 1,330 Web of Science: 92 Crossref: 104

Original Article

Comparison of LI-RADS 2018 and KLCA-NCC 2018 for noninvasive diagnosis of hepatocellular carcinoma using magnetic resonance imaging

Sunyoung Lee, Seung-seob Kim, Dong ryul Chang, Hyerim Kim, Myeong-Jin Kim

Clin Mol Hepatol. 2020;26(3):340-351. Published online June 4, 2020

DOI: https://doi.org/10.3350/cmh.2020.0004

View: 10091 Download: 230 Web of Science: 46 Crossref: 49

Review

Detect or not to detect very early stage hepatocellular carcinoma? The western perspective

Ju Dong Yang

Clin Mol Hepatol. 2019;25(4):335-343. Published online March 29, 2019

DOI: https://doi.org/10.3350/cmh.2019.0010

View: 12326 Download: 260 Web of Science: 46 Crossref: 43

Comparison of international guidelines for noninvasive diagnosis of hepatocellular carcinoma: 2018 update

Tae-Hyung Kim, So Yeon Kim, An Tang, Jeong Min Lee

Clin Mol Hepatol. 2019;25(3):245-263. Published online February 14, 2019

DOI: https://doi.org/10.3350/cmh.2018.0090

View: 21067 Download: 1,064 Web of Science: 156 Crossref: 163

Gadoxetic acid-enhanced magnetic resonance imaging: Hepatocellular carcinoma and mimickers

Yeun-Yoon Kim, Mi-Suk Park, Khalid Suliman Aljoqiman, Jin-Young Choi, Myeong-Jin Kim

Clin Mol Hepatol. 2019;25(3):223-233. Published online January 21, 2019

DOI: https://doi.org/10.3350/cmh.2018.0107

View: 11959 Download: 433 Web of Science: 31 Crossref: 34

Contrast-enhanced ultrasound (CEUS) liver imaging reporting and data system (LI-RADS) 2017 – a review of important differences compared to the CT/MRI system

Tae Kyoung Kim, Seung Yeon Noh, Stephanie R Wilson, Yuko Kono, Fabio Piscaglia, Hyun-Jung Jang, Andrej Lyshchik, Christoph F. Dietrich, Juergen K. Willmann, Alexander Vezeridis, Claude B Sirlin

Clin Mol Hepatol. 2017;23(4):280-289. Published online September 15, 2017

DOI: https://doi.org/10.3350/cmh.2017.0037

View: 17321 Download: 424 Web of Science: 103 Crossref: 104

Original Article

Glypican-3 level assessed by the enzyme-linked immunosorbent assay is inferior to alpha-fetoprotein level for hepatocellular carcinoma diagnosis

Yejoo Jeon, Eun Sun Jang, Yun Suk Choi, Jin-Wook Kim, Sook-Hyang Jeong

Clin Mol Hepatol. 2016;22(3):359-365. Published online September 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0033

View: 13429 Download: 153 Web of Science: 24 Crossref: 22

Review

Non-alcoholic fatty liver diseases: update on the challenge of diagnosis and treatment

Hyunwoo Oh, Dae Won Jun, Waqar K Saeed, Mindie H Nguyen

Clin Mol Hepatol. 2016;22(3):327-335. Published online September 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0049

View: 16955 Download: 539 Web of Science: 53 Crossref: 53

Liver Imaging

Liver imaging reporting and data system (LI-RADS) version 2014: understanding and application of the diagnostic algorithm

Chansik An, Gulbahor Rakhmonova, Jin-Young Choi, Myeong-Jin Kim

Clin Mol Hepatol. 2016;22(2):296-307. Published online June 15, 2016

DOI: https://doi.org/10.3350/cmh.2016.0028

View: 13880 Download: 247 Web of Science: 50 Crossref: 45

Review

Benign hepatocellular nodules of healthy liver: focal nodular hyperplasia and hepatocellular adenoma

Massimo Roncalli, Amedeo Sciarra, Luca Di Tommaso

Clin Mol Hepatol. 2016;22(2):199-211. Published online May 18, 2016

DOI: https://doi.org/10.3350/cmh.2016.0101

View: 20407 Download: 626 Web of Science: 41 Crossref: 39

Case Report

Imaging findings for intravascular large B-cell lymphoma of the liver

Jungmin Bae, Hyo Keun Lim, Ha Young Park

Clin Mol Hepatol. 2015;21(3):295-299. Published online September 30, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.3.295

View: 8903 Download: 115 Web of Science: 6 Crossref: 6

A case of primary hepatic actinomycosis: an enigmatic inflammatory lesion of the liver

Yeon Jung Ha, Ji Hyun An, Ju Hyun Shim, Eun Sil Yu, Jong Jae Kim, Tae Yong Ha, Han Chu Lee

Clin Mol Hepatol. 2015;21(1):80-84. Published online March 25, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.1.80

View: 9123 Download: 107 Web of Science: 10 Crossref: 9

1 | 2 |

Viewed By 9996	Epidemiology of metabolic dysfunction-associated steatotic liver disease
Viewed By 7136	MAFLD: How is it different from NAFLD?
Viewed By 5122	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 4655	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4609	Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment

Cited By 322	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 304	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 205	MAFLD: How is it different from NAFLD?
Cited By 104	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis
Cited By 103	Non-alcoholic fatty liver disease: Definition and subtypes

Search